PATHWAYS in Europe (PATHWAYS)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03519334 |
|
Recruitment Status :
Completed
First Posted : May 8, 2018
Last Update Posted : May 8, 2018
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease |
|---|
| Employment |
Introduction: One out four people experience any long-lasting health problem in Europe. Individuals with chronic diseases often experience work-related problems, leading to negative consequences at individual and societal level. The rising prevalence of chronic diseases as well as the current economic recession made this issue even more problematic, requiring action in terms of innovative strategies to improve the participation of these persons in the labor market.
The PATHWAYS objectives are:
- To identify integration and re-integration strategies that are available in Europe and beyond and to determine their effectiveness (systematic literature review)
- To assess the specific employment related needs of persons with chronic diseases and mental disorders (e-survey including people with chronic health conditions)
- To develop guidelines supporting the implementation of effective professional integration and reintegration strategies. (expert consultation survey)
Methods:
PATHWAYS is a multi-informant approach study. Information will be gathered from different sources:
- Systematic literature review,
- An expert consultation study (Including NGOs, patient's organizations and advocacy organizations operating at European Level). Experts will be searched by Internet. Questionnaire will be completed by e-mail
- an e-Survey including people with chronic health conditions. The Clinical Record Form (CRF) will be online (Google forms). Participation will be free. Any people who meet the inclusion criteria can log in and complete it. The dissemination of the CRF will be done via relevant patient's associations. The CRF will be also published in the patient association's websites, if possible
Hypothesis:
- Literature will focus on the negative points of experiencing chronic health problems in the workplace rather than analysing the professional needs of people with these health conditions
- There will be a set of professional needs that will be shared across different chronic health condition groups and that can be targeted in common preventive strategies
- There will be a considerable gap between the existing employment strategies (i.e. services, systems and policies) and the real employment needs of people with chronic health conditions
| Study Type : | Observational |
| Actual Enrollment : | 686 participants |
| Observational Model: | Other |
| Time Perspective: | Cross-Sectional |
| Official Title: | PArticipation To Healthy Workplaces And Inclusive Strategies in the Work Sector |
| Actual Study Start Date : | May 2015 |
| Actual Primary Completion Date : | June 2017 |
| Actual Study Completion Date : | December 2017 |
| Group/Cohort |
|---|
|
Chronic health condition group/study
People with any of the following chronic health conditions: Diabetes, Chronic obstructive Pulmonary Disease, Major Depression, Dysthymia, Migraine, Back & Neck Pain, Cancer, Ischemic Heart Disease
|
|
Expert consultation group/study
Relevant contacts from advocacy organizations operating at European level for the professional integration of people with chronic health conditions.
|
- Employment needs [ Time Frame: One time point assessment. Period of data collection: An average of 3 years (2016-2018) ]Any environmental or personal factor that impact on the professional integration of people with chronic health conditions. This definition has been conceptualized according to the International Classification of Disability and Health's framework (World Health Organization, 2001). This outcome will be collected in the e-survey study (including people with chronic health conditions)
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years to 65 Years (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
Chronic health conditions will be defined by people with self reported diagnosis of any of the following health conditions: Diabetes, Chronic obstructive Pulmonary Disease, Major Depression, Dysthymia, Migraine, Back & Neck Pain, Cancer, Ischemic Heart Disease (According to International Classification of Diseases 10th version (ICD-10)
Experts will be people working in advocacy organizations. For example, NGOs and patient's associations. These associations shuld be aimed ar enhancing professional integration of people with chronic health conditions
As PATHWAYS include different studies and methodologies, different inclusion and exclusion criteria are defined for each study
People with Chronic health condition study:
Inclusion Criteria:
- People with self-reported diagnosis of chronic health conditions (i.e Diabetes, Chronic obstructive Pulmonary Disease, Major Depression, Dysthymia, Migraine, Back & Neck Pain, Cancer, Ischemic Heart Disease)
- Participants living in European Union (EU-28)
- Working age: 18-65 years
Exclusion Criteria:
- Younger than 18 years
- No residents in European Union (EU-28)
Expert consultation study:
Inclusion Criteria:
- People working in Advocacy organizations. These organizations should meet all the following criteria: i) their main activities should be addressed at (re)integrating people with chronic health conditions into the workforce ii) they should operate at European level, and iii) they should have at least 3 years of experience in the field.
- Working age: 18-65 years
Exclusion Criteria:
- Advocacy organizations not operating at European Union Level
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03519334
| Austria | |
| KABEG Gailtal-Klinik | |
| Hermagor, Austria | |
| Czechia | |
| Charles University Czech Republic | |
| Praha, Czechia | |
| Germany | |
| Ludwig Maximilian University | |
| Munich, Germany | |
| Greece | |
| University of Thessaly | |
| Thessaloníki, Greece | |
| Italy | |
| Foundation IRCCS Neurological Institute Carlo Besta | |
| Milan, Italy | |
| Norway | |
| Oslo and Akershus University College of Applied Sciences | |
| Oslo, Norway | |
| Poland | |
| Jagiellonian University Medical College | |
| Kraków, Poland | |
| Slovenia | |
| University Rehabilitation Institute, Republic of Slovenia | |
| Ljubljana, Slovenia | |
| Spain | |
| Fundació Sant Joan de Déu | |
| Sant Boi De Llobregat, Barcelona, Spain | |
| Universidad Autonoma de Madrid | |
| Madrid, Spain, 28029 | |
| Principal Investigator: | Jose Luis Mateos, MD, PhD | Universidad Autonoma de Madrid |
| Responsible Party: | Maria Cabello, PhD, Universidad Autonoma de Madrid |
| ClinicalTrials.gov Identifier: | NCT03519334 |
| Other Study ID Numbers: |
PATHWAYS2020 HP-PJ-2014-663474 ( Other Grant/Funding Number: European Commission ) |
| First Posted: | May 8, 2018 Key Record Dates |
| Last Update Posted: | May 8, 2018 |
| Last Verified: | November 2017 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | Undecided |
| Plan Description: | A sharing plan description has to be still agreed between different Principal Investigators |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Employment Return to work Career Mobility |
Employment supported Workplace Chronic disease |